Corporate Banner
Satellite Banner
Biomolecular Screening
Scientific Community
 
Become a Member | Sign in
Home>News>This Article
  News
Return

RAN Biotechnologies Announces Distributorship Agreement with Fluigent

Published: Wednesday, July 16, 2014
Last Updated: Tuesday, July 15, 2014
Bookmark and Share
Agreement with Fluigent in France provides industry-leading solution for droplet microfluidic applications throughout EU region.

RAN Biotechnologies has entered into a distributorship  agreement with Fluigent  for distribution of RAN Biotechnologies products in Europe. 

“We are very excited to be distributing the products of RAN Biotechnologies,” said Dr. Jérémie Weber, CTO and co-founder of Fluigent. “Their chemicals and solutions are the state-of-the-art for droplet microfluidics. We believe the combination of RAN Biotechnologies reagents and our microfluidic instruments will lead to a very powerful platform for droplet microfluidic applications.”

Droplet microfluidics is an alternative technology for Lab-on-a-chip systems, where manipulation of discrete micro-droplets is performed. Such a technology is compatible with many chemicals and biologicals and allows the programmation of various digital fluidic operations. These valuable advantages have the potential to enhance biomedical research and secure a rapidly growing market share in diagnostics and therapeutics. 

“Our expertise in synthetic and surface chemistry in general and in surfactants in particular, allows us to develop advanced materials for microfluidics”, said Dr. Roger Nassar, founder and President of RAN Biotechnologies. Dr. Nassar added, “Partnering with Fluigent is a major step in our exposure efforts in Europe after winning the Young Entrepreneurs initiative (YEi’13) award, which is organized by the French Embassy in the United States and the French Innovation Network (Retis). It will help us to reach a wider microfluidic market and allow us to be part of important new technologies by advancing lab-on-a-chip applications.”

RAN Biotechnologies’ fluorosurfactants and microfluidic surface coatings stabilize water-in-oil emulsions for droplet microfluidics and can encapsulate biologicals, such as DNA, RNA, cells and proteins, permitting their study and interrogation. High-throughput single cell screening, DNA amplification and chemical reactions are some of the manipulations performed inside these unique droplets. 


Further Information

Join For Free

Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 3,300+ scientific posters on ePosters
  • More than 4,900+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.


Scientific News
Gene Terapy for Muscle Wasting Developed
New gene therapy could save millions of people suffering from muscle wasting disease.
Detecting Alzheimer's with Smell Test
Odour identification test may offer low-cost alternative for predicting cognitive decline and detecting early-stage Alzheimer’s disease.
Fighting Cancer Through Protein Pathways
Researchers have found a new drug target within a protein production pathway critical to regulating growth and proliferation of cells.
Mutations in DNA-Repair Genes Found in Advanced Prostate Cancers
New findings indicate that nearly 12% of male advanced prostate cancer sufferers have inherited mutation in DNA-repair genes.
Molecule May Affect Gaucher, Parkinson's Disease
Research has identified a molecule that restores activity of a dysfunctional enzyme linked to Gaucher and Parkinson's disease.
Targeting BRAF Mutations in Thyroid Cancer
Treating metastatic thyroid cancer patients harboring a BRAF mutation with vemurafenib showed anti-tumor activity in a third of patients.
Plant Compounds Fight Together Against Colon Cancer
Research shows treating colon cancer cells with curcumin, then silymarin is more effective than treatment with each individually.
New Centre Offers Ultra-Speed Protein Analysis
UW-Madison researchers to establish development centre for next-gen protein measurement technologies.
Drug Candidates Reduce Abnormal Protein Production
New drug candidates improve cell ability to catch miss-folded proteins that could cause deadly diseases.
Supercomputing and Drug Discovery
New biotech company uses supercomputer simulations to speed up drug discovery and biotech molecule development.
SELECTBIO

SELECTBIO Market Reports
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,300+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,900+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!